S0777 (multiple myeloma trial)

URI: https://gptkb.org/entity/S0777_(multiple_myeloma_trial)
GPTKB entity
Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:clinical_trial
gptkbp:conditionStudied multiple myeloma
gptkbp:contrastsWith lenalidomide and dexamethasone
gptkbp:foundIn addition of bortezomib improved progression-free and overall survival
gptkbp:fullName Southwest Oncology Group S0777 trial
https://www.w3.org/2000/01/rdf-schema#label S0777 (multiple myeloma trial)
gptkbp:intervention gptkb:dexamethasone
gptkb:lenalidomide
gptkb:bortezomib
lenalidomide and dexamethasone
gptkbp:location gptkb:United_States
gptkbp:number NCT00644228
gptkbp:period Phase III
gptkbp:population newly diagnosed multiple myeloma patients not intended for immediate autologous stem-cell transplant
gptkbp:principalInvestigator gptkb:Shaji_Kumar
gptkbp:publishedIn gptkb:New_England_Journal_of_Medicine
gptkbp:publishedResults 2017
gptkbp:result overall survival
progression-free survival
gptkbp:sponsor gptkb:Southwest_Oncology_Group
gptkbp:startYear 2008
gptkbp:bfsParent gptkb:SWOG_Cancer_Research_Network
gptkbp:bfsLayer 7